Eliminating perinatal transmission of hepatitis B virus: it is time for action
Authors:
Open Access
- 25 July 2024
- journal article
- research article
- Published by Wiley in Journal of the International AIDS Society
- Vol. 27 (7) , e26337
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- A measles and rubella vaccine microneedle patch in The Gambia: a phase 1/2, double-blind, double-dummy, randomised, active-controlled, age de-escalation trialThe Lancet, 2024
- Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling studyThe Lancet Gastroenterology & Hepatology, 2023
- Hepatitis B vaccine delivered by microneedle patch: Immunogenicity in mice and rhesus macaquesVaccine, 2023
- Status of HBV birth dose vaccination in Africa: the impact of COVID-19 and Gavi support on policy developmentThe Lancet Gastroenterology & Hepatology, 2023
- Estimating the health impact of vaccination against ten pathogens in 98 low-income and middle-income countries from 2000 to 2030: a modelling studyThe Lancet, 2021
- Feasibility, benefits, and cost-effectiveness of adding universal hepatitis B and syphilis testing to routine antenatal care services in Thai Nguyen province, VietnamInternational Journal of STD & AIDS, 2020
- Integrated approach for triple elimination of mother-to-child transmission of HIV, hepatitis B and syphilis is highly effective and cost-effective: an economic evaluationInternational Journal of Epidemiology, 2019